Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD

Clinical trial NCT00191698 · COMPLETED

Trial details

NCT number: NCT00191698
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Oppositional Defiant Disorder

Start date: 2003-12-01
Primary completion: 2005-06-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.